Mode
Text Size
Log in / Sign up

Impact of Lifestyle and Nursing Interventions on Quality of Life in Gynecologic CancersNursing and lifestyle support improve quality of life for ovarian cancer

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Nursing and lifestyle interventions significantly improved quality of life specifically in ovarian cancer patients at 6 months.

This meta-analysis evaluated the impact of lifestyle and gynecologic oncology nursing interventions on the quality of life (QoL) for women diagnosed with ovarian and endometrial cancers. The study included 915 patients across various clinical settings to determine if integrated support programs could mitigate the physical and emotional burdens of these malignancies.

Results demonstrated a statistically significant improvement in QoL for patients with ovarian cancer at the six-month follow-up mark. However, no statistically significant differences were observed in QoL scores for patients with endometrial cancer or for mixed cancer cohorts at either three or six months. The data suggests that specific intervention components may resonate differently depending on the primary pathology.

Despite the positive findings for ovarian cancer, the evidence is characterized by very low certainty. Significant heterogeneity, varied study designs, and small individual sample sizes across the included trials limit the generalizability of the results. Clinicians should interpret these findings with caution when implementing these specific nursing protocols for mixed gynecologic cancer populations.

How this fits prior evidence

This meta-analysis addresses a gap in supportive care for gynecologic cancers. While prior evidence confirms that olaparib maintenance improves progression-free survival in advanced ovarian cancer and that certain nutrients are associated with lower risks of gynecological cancers, this study specifically evaluates the impact of nursing and lifestyle interventions on quality of life. The finding of improved quality of life in ovarian cancer patients at 6 months provides a specific supportive care outcome for that population.

Living with gynecologic cancer brings heavy physical and emotional challenges. New research looked at how specific nursing interventions and lifestyle changes could help women manage their daily lives better. The study looked at 915 women with ovarian and endometrial cancers to see if these extra layers of support made a difference.

The results showed a clear benefit for women with ovarian cancer. Those who received nursing and lifestyle support reported a significant improvement in their quality of life after six months. However, the same interventions did not show a significant difference for women with endometrial cancer or for groups with mixed types of cancer at the three or six-month marks.

It is important to note that the evidence for these findings is currently very low. Because the studies included were quite different from one another and the sample sizes were small, the results should be viewed with caution. While the improvement for ovarian cancer patients is promising, more consistent research is needed to confirm these effects.

What this means for you:
Nursing and lifestyle programs significantly improved quality of life for women with ovarian cancer after six months.

Common questions

Does this treatment help all types of gynecologic cancer?

The study found that these nursing and lifestyle interventions significantly improved quality of life specifically for women with ovarian cancer at the six-month mark. For women with endometrial cancer or mixed cancers, the study did not find a significant difference in quality of life at the three or six-month marks.

How much did the quality of life improve for ovarian cancer patients?

Women with ovarian cancer saw a significant improvement in their quality of life at six months. The study measured this with a mean difference of 4.28. However, because the evidence is of very low certainty due to varied study designs, these results should be interpreted carefully.

Is the evidence for these programs very strong?

The evidence is currently considered to be of very low certainty. This is because the studies involved had a lot of differences in how they were designed and what specific interventions were used. Because of these limitations, the findings should be viewed with caution.

Study Details

Study typeMeta analysis
EvidenceLevel 1
Follow-up6.0 mo
PublishedSep 2026
View Original Abstract ↓
This meta-analysis evaluated the impact of lifestyle and gynecologic oncology nursing interventions on quality of life (QoL). A systematic search conducted through June 2026 identified 1,123 records. Thirteen randomized controlled trials involving 915 women with gynecologic cancer were included. The impact of lifestyle and gynecologic oncology nursing interventions on QoL was evaluated using pooled mean differences (MDs) with 95% confidence intervals, using random-effects models for the general analyses and fixed-effect models for the cancer-specific subgroup analyses. Compared with controls, interventions significantly improved QoL in women with ovarian cancer (MD 4.28, 95% CI: 0.45-8.10, p = 0.03; I = 0%). No significant differences emerged for 6-month QoL in mixed cancers (MD 2.11, 95% CI: -0.90-5.12, p = 0.17; I = 71%), endometrial cancer at 6 months (MD 2.00, 95% CI: -1.49-5.49, p = 0.26; I = 0%) or mixed cancers at 3 months (MD 6.43, 95% CI: -0.16-13.01, p = 0.06; I = 74%). However, marked heterogeneity, varied designs and interventions, small sample sizes, and variable risk of bias limit the certainty of the findings, which warrant cautious interpretation and confirmation through robust, standardized trials. Lifestyle and gynecologic oncology nursing interventions significantly improved QoL only in women with ovarian cancer at 6 months. However, substantial heterogeneity, methodological limitations, and very low-certainty evidence warrant cautious interpretation, and larger standardized trials are needed.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.